The content on this site is intended for healthcare professionals only
Dr Anthony El-Khoueiry presents at a press conference at ASCO 2015 findings from a phase I/II study that suggest nivolumab is safe and effective in advanced liver cancer.
Read the news article or watch the interview for more.
Talquetamab plus teclistamab shows promise in true extramedullary multiple myeloma
Isatuximab plus lenalidomide and dexamethasone with bortezomib as a new standard of care for NDMM TI non-frail patients
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Use of bispecifics and CAR T cells in South America
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Guiding transplant decisions in multiple myeloma with MRD
Revolutionising multiple myeloma treatment with CAR T-Cell therapies
Durvalumab plus bevacizumab, added to TACE, shows benefit for unresectable hepatocellular carcinoma
ASCO 2023: Highlights and analysis
